BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September

Day

• 1
• 2
• 3
• 4
• 5
• 8
• 9
• 10
• 11
• 12
• 15

• Press Releases

  Belite Bio Announces Completion of DRAGON, a 2-Year, Phase 3 Trial of Oral Tinlarebant in the Treatment of Stargardt Disease

  September 15, 2025

   · 

  4 min read
• Press Releases

  Progress in clinical development for Alzheimer’s and other indications: Galimedix Therapeutics successfully completes Phase 1 study with oral small molecule, GAL-101, an amyloid beta aggregation modulator

  September 15, 2025

   · 

  4 min read
• Press Releases

  Cocrystal Pharma Showcases CDI-988, the First Oral Antiviral in Development for Norovirus Infection, in a Podium Presentation at the International Calicivirus Conference

  September 15, 2025

   · 

  5 min read
• Press Releases

  Cullinan Therapeutics to Participate in Fireside Chat at the Stifel 2025 Virtual Immunology and Inflammation Forum

  September 15, 2025

   · 

  1 min read
• Press Releases

  Opus Genetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - September 12, 2025

  September 15, 2025

   · 

  2 min read
• Press Releases

  Innate Pharma Announces Its Participation in the 25th Edition of the European Midcap Event

  September 15, 2025

   · 

  4 min read
• Press Releases

  Polyrizon Reports Successful Intranasal Delivery of PL-14 Allergy Blocker in Latest Study

  September 15, 2025

   · 

  5 min read
• Press Releases

  Pulnovo Medical Receives two IDE approvals for PADN system’s clinical trials with CMS coverage

  September 15, 2025

   · 

  2 min read
• Press Releases

  Vicore to Present at Pareto Securities’ 16th Annual Healthcare Conference

  September 15, 2025

   · 

  1 min read